メニュー 戻る[Session 2]Clinical / ECG

8th DIA Cardiac Safety Workshop in Japan


[Session 2]Clinical / ECG

Session Chair(s)

Atsushi  Sugiyama, MD, PhD

Atsushi Sugiyama, MD, PhD

  • Professor and Chairman, Department of Pharmacology
  • Toho University Faculty of Medicine, Japan
Kyosuke  Takeshita, MD, PhD

Kyosuke Takeshita, MD, PhD

  • Department of Clinical Laboratory Medicine
  • Saitama Medical Center, Saitama Medical University, Japan

Speaker(s)

Börje C. Darpö, MD, PhD

Replacing the Thorough QT study with Concentration-QTc analysis applied to First-in-Human studies – recent trends and experience from interactions with regulators

Börje C. Darpö, MD, PhD

  • Chief Scientific Officer, Cardiac Safety
  • ERT, Sweden
Kaori  Shinagawa, MD, PhD

Current status and future perspective of clinical proarrhythmic risk assessment from a regulatory point of view

Kaori Shinagawa, MD, PhD

  • Senior Scientist for Clinical Medicine, Office of New Drug II
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Jorg  Taubel, MD, FFPM

Reasons why it is difficult to evaluate cardiac safety for antidiabetic drugs - Findings obtained in a type 1 diabetes study examining the effects of diet on normal and insulin-deficient subjects

Jorg Taubel, MD, FFPM

  • Chief Executive Officer
  • Richmond Pharmacology, United Kingdom
Boaz  Mendzelevski, MD

Boaz Mendzelevski, MD

  • Consultant Cardiologist
  • Cardiac Safety Consultants Ltd., United Kingdom

お問い合わせ

Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574